| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.016 | 0.9 |